glp 1 agonist and dpp 4 inhibitor GLP-1 receptor agonists DPP-4 inhibitors Pathway, Pharmacodynamics fig2.gif
Description
[DOI] [PubMed] [Google Scholar] 145.Ligumsky H., et al

Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
10.2337/db07-0100 27
According to the American Diabetes Association (ADA), GLP-1 receptor agonists are now recommended as a first-line treatment in certain high-risk patients, especially those with established cardiovascular disease

Despite their promise, GLP-1 drugs need to be treated with caution